Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cochrane Database of Systematic Reviews, 2022, 11, S. CD014384-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2022
- Event
-
Veröffentlichung
- (where)
-
Weinheim
- (who)
-
Wiley
- (when)
-
2022
- Creator
-
Rodolico, Alessandro
Siafis, Spyridon
Bighelli, Irene
Samara, Myrto T.
Hansen, Wulf-Peter
Salomone, Salvatore
Aguglia, Eugenio
Cutrufelli, Pierfelice
Bauer, Ingrid
Baeckers, Lio
Leucht, Stefan
- DOI
-
10.1002/14651858.cd014384.pub2
- URN
-
urn:nbn:de:bvb:384-opus4-1187879
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rodolico, Alessandro
- Siafis, Spyridon
- Bighelli, Irene
- Samara, Myrto T.
- Hansen, Wulf-Peter
- Salomone, Salvatore
- Aguglia, Eugenio
- Cutrufelli, Pierfelice
- Bauer, Ingrid
- Baeckers, Lio
- Leucht, Stefan
- Universität Augsburg
- Wiley
Time of origin
- 2022
Other Objects (12)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia
The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia
Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963
Dose rechteckig, Dose Blätter und Dose Punkte, 1936
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia
The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia
Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963
Dose rechteckig, Dose Blätter und Dose Punkte, 1936
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia
The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia
Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis
Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
Dose Distelfink, Dose Blütenzweig und Dose Aurorafalter, 1963